Prity Yadav | Cell Death Pathway | Best Researcher Award

Posted on by sciencefather

Ms. Prity Yadav | Cell Death Pathway | Best Researcher Award

Ms. Prity Yadav, UNIVERSITY OF RAJASTHAN, JAIPUR, India

Prity Yadav is a dedicated research scholar at the Department of Zoology, University of Rajasthan, Jaipur, India. Under the guidance of Prof. P.C. Mali, she is pursuing a PhD focused on nanotechnology and reproductive biomedicine. With a strong academic foundation including an M.Sc. in Zoology and CSIR-NET-JRF qualification, she currently receives the Senior Research Fellowship (SRF) from CSIR, Delhi. Her interdisciplinary research combines herbal medicine and nanoscience to develop eco-friendly contraceptive strategies, aiming to revolutionize non-hormonal fertility control. Prity has published 11 research papers in reputed journals indexed in SCI and Scopus, and actively contributes to the scientific community through her work. A member of the Indian Science Congress Association, she is passionate about public health, sustainability, and the responsible use of nanobiotechnology for population control and reproductive health. Her work holds significant promise for advancing global reproductive healthcare through innovative, natural, and non-invasive solutions.

Publication Profile: 

Google Scholar

✅ Strengths for the Award:

  1. Focused and Impactful Research Area
    Prity Yadav’s interdisciplinary research on nanotechnology and reproductive biomedicine is both relevant and innovative, especially in addressing global concerns like non-hormonal contraception, male fertility regulation, and eco-friendly biomedical alternatives.

  2. Consistent Publication Record
    With 11 publications in reputed SCI and Scopus-indexed journals, her research contributions are well-documented and consistently recognized in the academic community.

  3. Research Innovation
    Her work in green synthesis of silver nanoparticles using medicinal plant extracts for antifertility treatments reflects high originality and societal relevance.

  4. Academic Excellence
    She has cleared CSIR-NET-JRF and is currently receiving SRF from CSIR, showing national-level academic competitiveness.

  5. Sustainability and Public Health Focus
    Her projects promote natural, sustainable alternatives to conventional fertility control methods, aligning with public health policy and eco-conscious innovation.

  6. Active Membership in Scientific Community
    Her involvement in organizations such as The Indian Science Congress Association supports her engagement in broader scientific discourse.

🔧 Areas for Improvement:

  1. International Collaborations & Exposure
    Participation in international research collaborations, conferences, or exchange programs would further enrich her global perspective and strengthen her research profile.

  2. Patent Filing and Intellectual Property
    Considering the novelty of her nanoformulations, pursuing patents could enhance the impact and translational value of her work.

  3. Industry Engagement
    Involvement in consultancy or industry-based projects would bridge the gap between lab research and real-world application.

  4. Editorial and Peer Review Roles
    Taking on editorial responsibilities or peer-review contributions would boost her academic service profile.

🎓 Education:

Prity Yadav has a solid academic background in life sciences, specializing in Zoology. She completed her Master of Science (M.Sc.) in Zoology with distinction, focusing on reproductive physiology and applied biology. Demonstrating her academic excellence, she cleared the highly competitive CSIR-NET-JRF examination, qualifying for Junior Research Fellowship and later advancing to Senior Research Fellowship (SRF) funded by CSIR, New Delhi. She is currently enrolled in the PhD program at the University of Rajasthan, Jaipur, under the supervision of Prof. P.C. Mali in the Department of Zoology. Her academic path reflects a consistent focus on animal biology, toxicology, and molecular studies related to fertility and reproduction. Her strong theoretical knowledge, combined with hands-on laboratory training in nanoscience and biomedical research, sets a solid foundation for her innovative research. Prity’s education is a blend of traditional life sciences and modern interdisciplinary tools like nanotechnology and phytomedicine.

🧪 Experience:

Prity Yadav has accumulated significant research experience during her doctoral studies at the University of Rajasthan. With over four years of hands-on laboratory work, she has become proficient in nanoparticle synthesis, in vivo animal experimentation, biochemical analysis, and histopathological techniques. Her research focuses on developing green-synthesized silver nanoparticles using herbal extracts and evaluating their antifertility effects in male rodents. She has co-authored 11 publications in reputable journals and collaborated with fellow researchers on interdisciplinary projects involving herbal pharmacology, nanomedicine, and reproductive biology. While she has no direct industry consultancy experience, her academic research aligns closely with pharmaceutical applications. She frequently presents her findings in national and international conferences and is an active member of the Indian Science Congress Association. Prity’s experience highlights her commitment to scientific rigor, ethical research practices, and a vision for creating sustainable healthcare solutions through biocompatible nanotechnologies.

🔬 Research Focus:

Prity Yadav’s research lies at the intersection of nanotechnology and reproductive biomedicine, with an emphasis on developing herbal-based, non-hormonal antifertility agents. Her work explores the green synthesis of silver nanoparticles using medicinal plant extracts, aiming to enhance bioavailability and targeted delivery of active phytoconstituents. The ultimate goal of her research is to create eco-friendly, reversible male contraceptive methods with minimal side effects. She focuses on evaluating the impact of these nanoparticles on male reproductive systems through in vivo studies using rodent models. Her findings contribute to a deeper understanding of reproductive toxicity, oxidative stress, and fertility regulation mechanisms. This research addresses global challenges such as overpopulation and limited access to safe male contraceptives. Prity’s interdisciplinary approach supports sustainable healthcare by integrating traditional herbal knowledge with modern nanoscience, opening new avenues in contraceptive technology and public health policy.

📚 Publications Top Notes: 

  1. 🌿🔬 Herbal Nanoparticles to Control Fertility and Regulation: A Review

  2. 🧫🔥 Testicular Inflammation in Male Reproductive System

  3. 🍃🧪 Assessment of the Antifertility Potential of Silver Nanoparticles Synthesized Using Pongamia pinnata Leaf Extract in Male Wistar Rats

  4. 🌱📖 Medicinal Plants Potentials of Fertility Control, Antioxidant and Antimicrobial Activities: A Review

  5. 🧬🌿 Potential Antifertility and Antimicrobial Activities of Plants Used in Traditional Medicines: A Review

  6. 💊🦠 Cassia auriculata-Based Silver Nanoparticles: A Novel Approach to Combat Bacterial Infections

  7. 🌾🧠 A Review on Potential Antioxidant, Neuroprotective and Antidepressant Activities of Herbal Medicinal Plants

  8. ⚗️🧍‍♂️ Effects of Silver Nanoparticles of Putranjiva roxburghii on Reproductive Organs in Male Albino Rats

  9. 🌳🧬 Exploring the Impacts of Tecomella undulata Mediated Silver Nanoparticles on Male Rats Fertility and Reproductive Health

  10. 🍀🧫 An In Vitro Antioxidant Potential Analysis of Herbal Silver Nanoparticles Synthesized from Methanolic Leaf Extract of Cassia siamea

🧾 Conclusion:

Based on her scientific contributions, innovative research, and academic merit, Prity Yadav is a highly suitable candidate for the Best Researcher Award. Her work presents a unique and impactful solution to pressing challenges in public health and reproductive medicine. With scope for further growth in collaborative and translational domains, she stands out as a rising researcher making meaningful advances in her field.

Lingyan Zhou | Cell Death Pathway | Best Researcher Award

Posted on by sciencefather

Dr. Lingyan Zhou | Cell Death Pathway | Best Researcher Award

Dr. Lingyan Zhou , Shandong Provincial Hospital Affiliated to Shandong First Medical University , China

Dr. Lingyan Zhou is a dedicated neuroscientist and clinician specializing in the pathogenesis of neurodegenerative diseases, including Alzheimer’s and Parkinson’s disease. Currently serving in the Department of Neurology at Shandong Provincial Hospital affiliated with Shandong First Medical University, Dr. Zhou holds a doctorate and has made notable contributions to neurodegeneration research through high-impact publications and cutting-edge studies. Her work focuses on molecular mechanisms such as protein aggregation, homocysteinylation, and neuroprotection, with particular attention to α-synuclein and DJ-1. Dr. Zhou has co-authored more than 15 peer-reviewed articles in top-tier journals like Nature Communications, Science Advances, and Aging Cell, earning recognition for her insights into disease-modifying pathways. A researcher with a strong translational focus, she bridges the gap between bench and bedside, aiming to develop therapeutic strategies that can mitigate or reverse neurodegenerative processes. Her commitment to science and patient-centered research makes her a strong candidate for the Best Researcher Award.

Publication Profile:

Orcid

✅ Strengths for the Award:

  1. Strong Publication Record in High-Impact Journals
    Dr. Zhou has consistently published in top-tier journals such as Nature Communications, Science Advances, Aging Cell, and Movement Disorders, reflecting the significance and innovation of her work. Many of these are Q1 journals with high impact factors.

  2. Focused Research on Neurodegeneration
    Her core focus on the molecular basis of Alzheimer’s and Parkinson’s disease, especially novel mechanisms like N-homocysteinylation, STAT1-PARP1, and microRNA signaling, demonstrates depth and relevance to global health priorities.

  3. Translational Impact
    Her research bridges basic science and clinical application, particularly through studies on neuroprotection, early disease biomarkers, and potential therapeutic targets.

  4. Early Career Excellence
    Despite being in the early stages of her career, Dr. Zhou has already authored or co-authored over 17 peer-reviewed publications, many as first or corresponding author, which is exceptional at this stage.

  5. Multidisciplinary Collaborations
    Dr. Zhou’s collaborations with experts across genetics, immunology, bioinformatics, and neurology highlight her integrative approach to complex diseases.

  6. International Visibility
    Multiple articles are indexed in PubMed, Crossref, and DOIs, showing her research has international academic presence and reach.

⚠️ Areas for Improvement:

  1. Greater International Exposure
    While her publication record is strong, further participation in international neuroscience conferences, workshops, or global consortia would enhance visibility and foster leadership roles.

  2. Grant Leadership and Independent Funding
    As she progresses, securing independent research funding and leading grant-funded projects will further demonstrate research independence and strengthen her candidacy for top-tier awards.

  3. Mentorship and Teaching Roles
    Involvement in structured mentorship or supervision of Ph.D./postdoctoral researchers could be better highlighted to show contributions to research training and capacity building.

  4. Innovation Translation Pathway
    Filing patents or initiating translational collaborations with biotech/pharma could underline the practical applicability of her findings.

🎓 Education:

Dr. Lingyan Zhou received her doctorate from Wuhan University, one of China’s leading research institutions, between September 2020 and June 2023. During her Ph.D. training, she developed expertise in molecular neuroscience and translational medicine, with a specific focus on the pathological mechanisms underlying Parkinson’s and Alzheimer’s diseases. Her research explored cellular stress pathways, protein misfolding, and epigenetic regulation in neurodegeneration, leading to multiple first-author publications in high-impact journals. Her academic background provided a solid foundation in experimental techniques such as immunohistochemistry, gene expression analysis, and in vivo disease modeling. The interdisciplinary approach at Wuhan University enriched her understanding of both clinical neurology and basic neuroscience. This rigorous academic training has equipped Dr. Zhou with the analytical and research skills necessary for advancing innovation in neurodegenerative disease treatment.

🧪 Experience:

Since July 2023, Dr. Lingyan Zhou has been serving in the Department of Neurology at Shandong Provincial Hospital affiliated with Shandong First Medical University, where she engages in both clinical practice and translational neuroscience research. Prior to that, she completed her doctoral studies at Wuhan University, where she developed a deep interest in the role of homocysteine metabolism and genetic regulation in Parkinson’s disease. Over her career, she has collaborated with multidisciplinary teams to investigate molecular and cellular mechanisms of neurodegeneration and published extensively in internationally recognized journals. Her current position allows her to continue high-impact research while mentoring junior colleagues and participating in multi-center studies. Her combined experience in basic research, clinical neurology, and academic collaboration has established her as a key contributor in the field of neurodegenerative diseases, positioning her well for leadership roles and research recognition such as the Best Researcher Award.

🧠 Research Focus:

Dr. Lingyan Zhou’s research is centered on understanding the molecular and cellular mechanisms that drive neurodegenerative diseases, with an emphasis on Alzheimer’s and Parkinson’s disease. Her work has shed light on pathological protein modifications, such as N-homocysteinylation of α-synuclein and DJ-1, which contribute to protein aggregation and neurotoxicity. Additionally, she investigates the neuroprotective roles of vitamins, retinoic acid, and microRNAs in slowing disease progression. Dr. Zhou is also exploring how infectious diseases like SARS-CoV-2 may trigger or exacerbate neurological disorders, expanding the understanding of systemic factors in brain health. Her studies leverage both in vitro and in vivo models to unravel pathways involving STAT1, PARP1, and Notch signaling. By identifying potential therapeutic targets and biomarkers, her research aims to guide the development of novel treatment strategies that could improve outcomes for patients suffering from movement disorders and cognitive decline.

📚 Publications Top Notes:

  1. 🧪 N-homocysteinylation of alpha-synuclein promotes its aggregation and neurotoxicity – Aging Cell (2022)

  2. 🧠 Association of vitamin B2 intake with cognitive performance in older adults: a cross-sectional study – J Transl Med (2023)

  3. 🧬 Homocysteine and Parkinson’s disease – CNS Neurosci Ther (2023)

  4. 🧴 Retinoic Acid Prevents alpha-Synuclein Preformed Fibrils-Induced Toxicity via Inhibiting STAT1-PARP1 Signaling – Mol Neurobiol (2023)

  5. 🧫 N-homocysteinylation of DJ-1 promotes neurodegeneration in Parkinson’s disease – Aging Cell (2024)

  6. 🦠 SARS-CoV-2: Underestimated damage to nervous system – Travel Med Infect Dis (2020)

  7. 💊 Potential therapeutic drugs for ischemic stroke based on bioinformatics analysis – Int J Neurosci (2019)

  8. 🧬 PTPN22 Gene Polymorphisms and Stroke Susceptibility – Dis Markers (2019)

  9. 🧪 IL-18 Gene Polymorphisms and Risk of Ischemic Stroke: A Meta-analysis – Neuroreport (2019)

  10. 🚬 Aromatic hydrocarbon receptor links smoking and rheumatoid arthritis – Clin Exp Rheumatol (2020)

🧾 Conclusion:

Dr. Lingyan Zhou demonstrates an exceptional trajectory for a young neuroscience researcher. Her deep and original contributions to unraveling molecular mechanisms in neurodegeneration, particularly Parkinson’s and Alzheimer’s disease, make her highly deserving of recognition. The breadth and quality of her publication record—combined with her translational outlook—signal a rising star in neurodegenerative disease research.

Sen Wang | Cancer Cell Biology | Best Researcher Award

Posted on by sciencefather

Ms. Sen Wang | Cancer Cell Biology | Best Researcher Award

Ms. Sen Wang , Affiliated Hospital of Jining Medical College , China

Dr. Wang Sen is an accomplished researcher and Deputy Chief Technician at the Affiliated Hospital of Jining Medical University. With a Ph.D. in Pharmaceutical Engineering and a postdoctoral fellowship at Shandong University of Traditional Chinese Medicine, he has developed deep expertise in molecular oncology, tumor microenvironments, and translational medicine. His career spans over a decade, marked by significant research in gastrointestinal and renal cancers, exploring mechanisms of autophagy, endothelial dysfunction, and tumor angiogenesis. Dr. Wang has led and contributed to several prestigious research projects, including National Natural Science Foundation grants. He has published in high-impact journals and holds patents that support translational applications in oncology. Recognized by peers and institutions alike, he received the Shandong Medical Association Youth Science and Technology Award. His work continues to push boundaries in cancer research, demonstrating strong scientific leadership and a commitment to improving therapeutic strategies.

Publication Profile: 

Scopus

✅ Strengths for the Award

  1. Extensive Research Background
    Dr. Wang has demonstrated a consistent and deep involvement in cutting-edge cancer research, especially focusing on tumor microenvironment regulation, autophagy, and angiogenesis—key areas in translational oncology.

  2. Prolific Publication Record
    He is the sole first author of several papers published in high-impact journals like British Journal of Cancer, Cell Death & Disease, and Scientific Reports. These contributions indicate scientific independence and strong writing and experimental skills.

  3. Leadership in Funded Projects
    He has served as Principal Investigator (PI) on multiple prestigious projects, including the NSFC Youth Fund and China Postdoctoral Foundation grants, which testifies to his research leadership and capability in securing competitive funding.

  4. Innovative Impact through Patents
    Dr. Wang is a co-inventor of three Chinese patents, including a novel therapeutic application of MT1G in renal cancer—highlighting a strong translational component in his research.

  5. Academic Awards and Recognition
    His receipt of the Shandong Medical Association Youth Science and Technology Award (Second Prize) in 2024 is an external validation of his scientific excellence at the provincial level.

  6. Collaborative and Interdisciplinary Approach
    His co-authorship with experts across molecular biology, pharmacology, and clinical research demonstrates a collaborative nature crucial for multidisciplinary medical advancements.

📈 Areas for Improvement

  1. International Recognition
    While Dr. Wang’s work is commendable within China, increasing collaboration or recognition on an international level (e.g., international conferences, global research networks) would further elevate his research visibility.

  2. Citations and Real-world Applications
    Some of his recent papers have not yet garnered citations. Continued dissemination, follow-up studies, and clinical application testing will help boost impact.

  3. Expanded Mentorship Role
    There is limited information on his mentorship of young scientists or PhD students. Strengthening academic mentorship could broaden his influence within the scientific community.

🎓 Education:

Dr. Wang Sen has pursued a comprehensive academic path in life sciences and medical research. He earned his Ph.D. in Pharmaceutical Engineering from Chongqing Medical University (2016–2019), following a Master’s degree in Biochemistry and Molecular Biology at the same institution (2013–2016). His foundational training began with a Bachelor’s degree in Biological Engineering from Jining University (2009–2013), where he laid the groundwork for his interest in molecular biology and drug development. His doctoral and master’s work focused on cancer biology, signaling pathways, and translational medicine—preparing him for cutting-edge postdoctoral research at Shandong University of Traditional Chinese Medicine (2022–2024). This academic journey has equipped him with strong theoretical and experimental skills that he applies in both clinical and laboratory settings.

🧪 Experience:

Dr. Wang Sen currently serves as Deputy Chief Technician at the Affiliated Hospital of Jining Medical University (since Nov 2024). Prior to this, he held the role of Chief Technician (2019–2024) at the same hospital, where he led several translational cancer research projects. His responsibilities include designing experimental protocols, overseeing clinical collaboration, and mentoring junior researchers. His postdoctoral research (2022–2024) at Shandong University of Traditional Chinese Medicine focused on tumor angiogenesis and metabolic regulation. Throughout his academic and professional journey, he has shown a keen interest in understanding cancer cell signaling, tumor-endothelial interactions, and the development of therapeutic targets. His multidisciplinary expertise makes him a vital contributor to collaborative projects in molecular medicine and drug discovery.

🏆 Awards and Honors:

Dr. Wang Sen’s contributions to medical research have earned him notable recognition. In 2024, he received the Shandong Medical Association Youth Science and Technology Award (Second Prize), celebrating his innovative work in cancer biology. He is also a co-inventor on three Chinese patents, including the application of MT1G protein inhibitors for renal cancer and methods related to small molecule metabolite ligands and exosome preparation. These patents demonstrate his commitment to translational research and innovation in therapeutic development. Additionally, his participation in collaborative high-impact publications and national grants has solidified his reputation as a rising leader in biomedical sciences. His academic integrity, technical depth, and consistent contributions to cutting-edge research make him an ideal candidate for recognition through prestigious awards like the Best Researcher Award.

🔬 Research Focus:

Dr. Wang Sen’s research centers on tumor microenvironment regulation, angiogenesis, autophagy, and tumor stem cell interactions, with a strong focus on gastrointestinal and renal cancers. His work often integrates cellular signaling, exosome biology, and gene expression regulation to understand cancer progression and metastasis. Key interests include pathways involving INSR/FGF5/ADRB2, ALDOC, and MT1G, which he investigates for their roles in tumor metabolism and vascular dynamics. Dr. Wang combines clinical relevance with basic science, aiming to translate molecular findings into diagnostic tools or therapeutic targets. His innovative studies on betulinic acid, p53-mediated pathways, and epigenetic modifications contribute to the broader field of precision oncology. His interdisciplinary approach—bridging pharmacology, molecular biology, and clinical application—positions him as a dynamic researcher capable of advancing medical science.

📚 Publications Top Notes:

  1. 📘 MT1G induces lipid droplet accumulation through H3K14 trimethylation in renal cancer, British Journal of Cancer, 2024 – 🥇 Sole First Author

  2. 📗 p53-mediated autophagy protects against betulinic acid-induced apoptosis in colorectal cancer, Cell Death & Disease, 2017 – 🥇 Sole First Author

  3. 📕 FOXS1 is regulated by GLI1/miR-125a-5p, promotes proliferation and EMT in gastric cancer, Scientific Reports, 2019 – 🥇 Sole First Author

  4. 📙 Identification of the human HAS3 promoter region, Biochemical and Biophysical Research Communications, 2015 – 🥇 Sole First Author

  5. 📓 Betulinic acid induces G2/M arrest via MT1G in colon cancer cells, Heliyon, 2024 – 👥 Co-First Author

  6. 📔 PCDH17 induces colorectal cancer metastasis by disrupting vascular barriers, Cell Death and Disease, 2025 – 🧬 Contributor

  7. 📒 OX40 activation drives tumor escape via S1P/YAP angiogenesis, Journal of Clinical Investigation, 2025 – 🧬 Contributor

🧾 Conclusion:

Dr. Wang Sen is a highly qualified and worthy candidate for the Best Researcher Award. His impressive portfolio—spanning publications, funded projects, patents, and recognized awards—shows that he is not only producing important knowledge but also moving toward real-world application in cancer therapeutics. With continued focus on global engagement and translational outcomes, he is poised to become a leading figure in molecular oncology. His scientific rigor, innovation, and leadership embody the spirit of this award.

Priyanshu Mathur | Cell Death Pathway | Best Researcher Award

Posted on by sciencefather

Assoc. Prof. Dr. Priyanshu Mathur | Cell Death Pathway | Best Researcher Award

Assoc. Prof. Dr. Priyanshu Mathur , SMS Medical College, Jaipur , India

Dr. Priyanshu Mathur is an esteemed expert in Pediatric Medicine and Genetics, serving as an Associate Professor at SMS Medical College, Jaipur, India. He is renowned for his pioneering work in rare diseases, neurometabolism, and newborn screening. With a robust academic background, Dr. Mathur holds an MD in Pediatrics, a PhD in Genetics (Honorary), and specialized training in clinical biochemical genetics and neurometabolism. He is actively involved in clinical research and education, focusing on inborn errors of metabolism and rare genetic disorders. Dr. Mathur’s leadership extends to founding India’s first Rare Diseases Registry and establishing a newborn screening lab. He has significantly impacted both clinical practice and academic spheres in India and abroad. He is an active member of various international networks and has contributed extensively to medical research and education, solidifying his position as a thought leader in pediatric genetics and rare diseases.

Publication Profile:

Scopus

Strengths for the Award:

Dr. Priyanshu Mathur exhibits a profound commitment to advancing pediatric medicine, particularly in the fields of genetics, neurometabolism, and rare diseases. His extensive academic and clinical contributions make him an exceptional candidate for the Best Researcher Award. Below are the key strengths that highlight his qualifications:

  1. Educational Excellence:
    • Dr. Mathur’s advanced qualifications, including a Masters in Neurometabolism & Cell Biology from the University of Barcelona and a Fellowship in Clinical Biochemical Genetics & Newborn Screening in the USA, underscore his expertise in rare metabolic disorders and genetic diseases.
    • His honorary PhD in Genetics further exemplifies his contributions to genetic research and medicine.
  2. Research and Clinical Leadership:
    • He has been instrumental in establishing the first Indian Rare Diseases Registry, which has provided valuable insights into rare disease prevalence in India (www.rarediseasesregistryindia.com).
    • His work in newborn screening and biochemical genetics, including his leadership in starting the NBS lab at J K Lone hospital, Jaipur, demonstrates a significant impact on early detection and management of genetic disorders.
    • His role as a Principal Investigator (PI) in DBT and ICMR-approved research projects highlights his ability to lead national-level research initiatives.
  3. Publication Record and Recognition:
    • Dr. Mathur has contributed extensively to the scientific literature, with numerous original articles and case reports, often focusing on rare diseases, pediatric genetics, and metabolic disorders.
    • His published works, along with his contributions to textbooks such as Rare Diseases in Pediatrics, exemplify his thought leadership.
    • He is also actively involved in peer review, further demonstrating his academic credibility.
  4. Clinical and Teaching Experience:
    • With years of experience as an Associate Professor at SMS Medical College and as a consultant at J K Lone Hospital, Dr. Mathur has shown excellence in clinical practice and teaching.
    • He is deeply involved in mentoring postgraduate students, guiding them in the fields of genetics and pediatrics, and helping shape the next generation of medical professionals.
  5. National and International Impact:
    • Dr. Mathur’s expertise is internationally recognized, with participation as a speaker and panelist at various international summits, including NBS Virtual Summit and Emory University sessions.
    • His role as a national faculty member for IAP programs and his advisory positions with organizations such as the Rare Disease India Foundation further underscore his leadership.

Areas for Improvement:

  1. Expansion of Research Focus:
    • Although Dr. Mathur has made immense contributions in metabolic genetics and rare diseases, there is potential for further exploration into emerging areas such as gene therapy, CRISPR-based technologies, and personalized medicine.
    • Collaborating with multidisciplinary teams to explore integrative approaches to pediatric genetic disorders could enrich his research portfolio.
  2. Further International Collaboration:
    • Increasing international collaborations, particularly in the context of clinical trials and large-scale multicenter studies, could significantly enhance the global impact of his work. This could provide broader insights and validation of his findings across diverse populations.
  3. Public Outreach and Advocacy:
    • While his contributions to academia are remarkable, further emphasis on public outreach programs to raise awareness about rare diseases and genetic conditions could increase their visibility in India and beyond.
    • Engaging with patient advocacy groups could help bridge the gap between research and patient care.

Education:

Dr. Priyanshu Mathur’s educational journey showcases a deep commitment to advancing knowledge in pediatric medicine and genetics. He earned his MBBS in 2005 from Vijayanagar Institute of Medical Sciences, Bellary, Karnataka, India, where he secured the first rank. He completed his MD in Pediatrics in 2010 from Dr. S. N. Medical College, Jodhpur, Rajasthan, India. His academic pursuits include a Masters in Neurometabolism & Cell Biology for Clinicians from the University of Barcelona, Spain (2022-2024). Dr. Mathur also underwent a Fellowship in Metabolic Genetics and Newborn Screening in Atlanta, USA (2018-2019), strengthening his expertise in the diagnosis and management of genetic disorders. His honorary PhD in Genetics from IIU in 2021 further bolstered his academic stature. His education equips him with an exceptional foundation in clinical genetics, pediatrics, and research, allowing him to contribute meaningfully to the field of medical science.

Experience:

Dr. Priyanshu Mathur’s professional experience spans over a decade, making him a leader in pediatric medicine and genetics. He is currently an Associate Professor at SMS Medical College, Jaipur, where he teaches and mentors future medical professionals. Dr. Mathur’s clinical expertise is evident in his role at J K Lone Hospital, Jaipur, where he oversees the Rare Diseases Clinic and newborn screening services. His experience extends internationally, having worked as a visiting assistant professor in clinical biochemical genetics and newborn screening in Atlanta, USA. He is deeply involved in clinical research, particularly in the field of genetic disorders and rare diseases, and has contributed to several national and international research projects. Dr. Mathur’s teaching roles include guiding postgraduate students and being a faculty member for various national courses and workshops. His work in establishing the first Indian Rare Diseases Registry and newborn screening lab has had a transformative impact on Indian healthcare.

Awards and Honors:

Dr. Priyanshu Mathur has earned multiple prestigious awards throughout his career, recognizing his dedication to research, teaching, and clinical excellence. In 2021, he received an Honorary Doctorate (PhD) in Genetics from IIU for his outstanding contributions to genetics and pediatric medicine. He was awarded a Fellowship in Clinical Biochemical Genetics & Newborn Screening in 2019, marking his specialization in metabolic genetics. In the same year, he received the Outstanding Faculty Award from the Principal of SMS Medical College, Jaipur, for his exceptional contributions to education. Dr. Mathur was also honored with the “Dakshata Praman Patra” at SMS Medical College, Jaipur, in 2016. Earlier in his career, he won the Silver Medal for paper presentation at a State Pediatric Conference in 2009 and was recognized as the Best Outgoing Student at VIMS, Bellary, in 2005. His awards reflect his commitment to advancing medical science and improving healthcare delivery.

Research Focus:

Dr. Priyanshu Mathur’s research primarily focuses on rare diseases, metabolic disorders, and inborn errors of metabolism. He has significantly contributed to the establishment of India’s first Rare Diseases Registry, which provides crucial insights into the prevalence and management of rare genetic conditions in the Indian population. His work in neurometabolism and newborn screening has been groundbreaking, particularly in identifying genetic disorders early and enabling early interventions. Dr. Mathur’s research has expanded the understanding of metabolic genetic diseases and their clinical management, making a considerable impact on patient care. He has also been involved in various clinical trials to evaluate the safety and efficacy of treatments for rare diseases such as Duchenne Muscular Dystrophy and Fabry Disease. His research is not only aimed at better clinical outcomes but also at educating the medical community and raising awareness about rare and inherited disorders. His work continues to shape the landscape of pediatric genetics in India.

Publications Top Notes:

  1. Prevalence of obesity and overweight in private schools of Jaipur city in 11-17 year age group children 📊
  2. Correlation study of various factors with germinal matrix intraventricular hemorrhage in preterm neonates 👶
  3. Evaluation of nutritional & educational intervention as KAP and outcome of children with SAM in malnutrition treatment center 🍽️
  4. Chloroquine vs co-artemether in uncomplicated malaria 🦠
  5. Comparison of risk factors and early morbidity in late preterm neonates and term neonates ⚖️
  6. Prevalence of impaired glucose tolerance test and diabetes in overweight, obese and apparently healthy adolescents 🏫
  7. Prevalence of overweight and obesity amongst adolescents and identification of risk factors 🍔
  8. Assessment of parents and child’s attitude as barrier to dietary compliance in celiac disease 🍞
  9. Study on clinical presentations, risk factors and short term outcome of hemorrhagic disease of newborn 🩸
  10. Epidemiological study of HIV-AIDS in children of western Rajasthan 🌍

Conclusion:

Dr. Priyanshu Mathur’s dedication to advancing pediatric medicine through groundbreaking research in genetics and rare diseases, along with his leadership in newborn screening and education, positions him as an exemplary candidate for the Best Researcher Award. His clinical expertise, substantial publication record, and impact on both national and international healthcare systems demonstrate that he is not only a skilled researcher but also a pioneering figure in improving the lives of children affected by genetic and metabolic disorders. With continued expansion into new areas of research and further global collaborations, Dr. Mathur can continue to make an even greater impact on pediatric healthcare worldwide.

 

 

 

Jorge Saraiva | Cell Death Pathway | Best Researcher Award

Posted on by sciencefather

Assoc. Prof. Dr Jorge Saraiva | Cell Death Pathway | Best Researcher Award

Assoc. Prof. Dr Jorge Saraiva , University of Aveiro , Portugal

Professor Jorge Manuel Alexandre Saraiva is an Associate Professor at the University of Aveiro, Portugal, specializing in high-pressure technologies. With a PhD in Biotechnology (Food Science and Engineering), his career spans over 27 years, during which he has become a leading figure in food safety and sustainability research. Professor Saraiva is renowned for his pioneering work in hyperbaric-storage (HS) and moderate-pressure pasteurization (MPP), which have revolutionized food storage and safety practices. He has contributed to over 334 publications, advancing both academic knowledge and practical applications in food science, biotechnology, and medical sterilization. His innovative research also extends to collaborations with global research institutions and industry leaders. Recognized as a Highly Cited Researcher in Agricultural Sciences (2021-2024), Professor Saraiva’s work has bridged the gap between academia and industry, emphasizing knowledge transfer for sustainable technological development.

Publication Profile:

Scopus

Strengths for the Award:

Dr. Jorge Saraiva stands out as a highly accomplished researcher in the field of Food Science and Biotechnology, with specialized expertise in high-pressure technologies, including hyperbaric-storage and moderate-pressure pasteurization. He has demonstrated exceptional contributions to food safety, sustainability, and biotechnology, having led 13 research projects and collaborated in 20 others, including numerous industry-related projects. His citation index of 11,363 and h-index of 51, as well as recognition as a Highly Cited Researcher by Clarivate Analytics from 2021 to 2024, highlight his impactful research. Furthermore, his innovative work in hyperbaric storage and pasteurization technologies not only enhances food safety but also offers sustainable alternatives to conventional food preservation methods.

Areas for Improvement:

While Dr. Saraiva’s work in high-pressure technologies has had significant practical applications, there could be an increased focus on interdisciplinary collaborations in emerging fields such as personalized nutrition, where his technologies might have unexplored potential. Engaging more with new scientific innovations in other sectors like agriculture or medicine could further broaden his research impact.

Education 

Professor Jorge Saraiva completed his PhD in Biotechnology, specializing in Food Science and Engineering, at the Portuguese Catholic University. His educational journey has been rooted in research, with an emphasis on food safety and sustainable technologies. Over the years, he has built an extensive academic foundation, specializing in the application of high-pressure and non-thermal technologies for food preservation. His academic career at the University of Aveiro has been marked by his dedication to integrating advanced scientific research with practical solutions for the food industry. Throughout his career, Professor Saraiva has committed to the advancement of food safety and sustainability, focusing on innovative preservation methods that reduce energy consumption and maintain food quality. His expertise has made him a respected figure both nationally and internationally, frequently collaborating with esteemed universities and research institutions on cutting-edge projects that influence food science and biotechnology.

Experience 

With over 27 years of experience, Professor Jorge Saraiva has made significant contributions to the fields of food science, biotechnology, and high-pressure technology. As an Associate Professor in the Chemistry Department at the University of Aveiro, he has led 13 research projects and participated in 20 others. His research has been pivotal in the development of hyperbaric-storage (HS) and moderate-pressure pasteurization (MPP), technologies that have transformed food safety protocols and sustainability in the food industry. He has worked on over 24 industry-focused projects, helping companies implement non-thermal processing technologies. Additionally, his extensive work in consultancy and his leadership in collaborations with global research institutions, including universities in Portugal, Spain, and Italy, have fostered innovations that extend beyond food preservation to medical applications. Professor Saraiva’s contributions have earned him recognition as a Highly Cited Researcher (2021-2024), cementing his status as a leader in his field.

Awards and Honors 

Professor Jorge Saraiva has received numerous prestigious awards and recognitions for his impactful research in food science and biotechnology. Notably, he has been recognized as a Highly Cited Researcher in Agricultural Sciences from 2021 to 2024 by Clarivate Analytics, a testament to his significant contributions to scientific advancement. In 2024, he was honored with the Cooperation Award from the University of Aveiro for his exceptional efforts in knowledge transfer to the food industry. His work on high-pressure technologies, particularly in food safety and sustainability, has earned him global recognition. He has also received accolades for his leadership in scientific advisory roles, influencing policies and guiding research directions in food processing and biotechnology. Professor Saraiva’s dedication to fostering collaborations with industry and academic institutions worldwide has led to groundbreaking advancements that address contemporary challenges in food preservation, sustainability, and public health.

Research Focus 

Professor Jorge Saraiva’s research focus centers on the application of high-pressure technologies to enhance food safety, sustainability, and quality. His pioneering work in hyperbaric-storage (HS) has introduced new methods for food storage at room temperature, offering an energy-efficient alternative to traditional refrigeration. He has also advanced moderate-pressure pasteurization (MPP) techniques that maintain the sensory qualities of sensitive foods like meat and fish while ensuring microbial safety. These innovations have had a profound impact on food processing and preservation, addressing global challenges in food security and sustainability. Additionally, Professor Saraiva has made strides in biotechnology, exploring non-thermal methods for bioactive compound extraction and sterilization processes with medical applications, such as intraocular lenses. His research extends to microbiology, fermentation processes, and food science, aiming to improve both the safety and nutritional quality of food products. His interdisciplinary approach continues to push the boundaries of applied science.

Publication Top Notes:

  1. Effects of pressure-based technologies on food lipids oxidation 🥩💡
  2. Hyperbaric inactivation at 150–250 MPa of Alicyclobacillus acidoterrestris spores at room temperature and effect of innovative technologies pre-treatments 🔬💪
  3. Novel cold and thermally pasteurized cardoon-enriched functional smoothie formulations: A zero-waste manufacturing approach 🍹♻️
  4. Potential of electric and pressure-based techniques for the inactivation of microorganisms in fresh fish 🐟⚡
  5. Quality Changes on Cod Fish (Gadus morhua) during Desalting Process and Subsequent High-Pressure Pasteurization 🐟🧂
  6. Production of Opuntia ficus-indica fortified breads: A comparative analysis of wheat and gluten-free varieties and the impact on phytochemicals and antioxidant capacity 🍞🌵
  7. Nonthermal high-pressure microalgae extracts: A new source of natural ingredients for cosmetics 🌱💄
  8. Impact of pH and High-Pressure Pasteurization on the Germination and Development of Clostridium perfringens Spores under Hyperbaric Storage versus Refrigeration 💥🍽️
  9. Influence of High-Pressure Processing and Microbial Transglutaminase on the Properties of Pea Protein Isolates 🥣🌱
  10. The effects of pressure-based processing technologies on protein oxidation 🧬🍖

Conclusion:

Dr. Jorge Saraiva’s extensive experience, high-impact publications, patents, and notable collaborations make him a highly deserving candidate for the Best Researcher Award. His contributions to food science and biotechnology, particularly in nonthermal food preservation methods, have set new standards for sustainability and efficiency in food processing.